Rejko Krüger

29.1k total citations · 1 hit paper
200 papers, 7.3k citations indexed

About

Rejko Krüger is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rejko Krüger has authored 200 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Neurology, 69 papers in Molecular Biology and 63 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rejko Krüger's work include Parkinson's Disease Mechanisms and Treatments (116 papers), Neurological disorders and treatments (52 papers) and Nuclear Receptors and Signaling (26 papers). Rejko Krüger is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (116 papers), Neurological disorders and treatments (52 papers) and Nuclear Receptors and Signaling (26 papers). Rejko Krüger collaborates with scholars based in Germany, Luxembourg and United States. Rejko Krüger's co-authors include Olaf Rieß, Lena F. Burbulla, Lüdger Schöls, Daniela Berg, Dirk Woitalla, Thomas Gasser, Paul Antony, Jörg B. Schulz, Christian Plewnia and Thomas Müller and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Rejko Krüger

195 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

2017 625 citations Lena F. Burbulla, Pingping Song et al. Science profile →

Peers

Countries citing papers authored by Rejko Krüger

Since Specialization

Citations

This map shows the geographic impact of Rejko Krüger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rejko Krüger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rejko Krüger more than expected).

Fields of papers citing papers by Rejko Krüger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rejko Krüger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rejko Krüger. The network helps show where Rejko Krüger may publish in the future.

Co-authorship network of co-authors of Rejko Krüger

This figure shows the co-authorship network connecting the top 25 collaborators of Rejko Krüger. A scholar is included among the top collaborators of Rejko Krüger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rejko Krüger. Rejko Krüger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Continuous Levodopa Delivery with an Intraoral Micropump System: An Open‐Label Pharmacokinetics and Clinical Study 2024 ·Movement Disorders ·C. Warren Olanow, Deborah McIntyre, Michele Matarazzo, Mika Leinonen, Andrew McGarry, Cornelia Kamp, (unknown), Margherita Torti, Rejko Krüger, José Á. Obeso, Fabrizio Stocchi, (unknown), Karl Kieburtz	5
2	Insulin Resistance Is a Modifying Factor for Parkinson's Disease 2024 ·Movement Disorders ·Alise Žagare, Ahmed Abdelmonem Hemedan, (unknown), (unknown), Gemma Gomez‐Giro, Paul Antony, Rashi Halder, Rejko Krüger, Enrico Glaab, Marek Ostaszewski, Giuseppe Arena, Jens C. Schwamborn	5
3	Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study 2023 ·Brain Sciences ·Odette Fründt, Anne-Marie Hanff, (unknown), (unknown), (unknown), (unknown), Carsten Buhmann, Rejko Krüger, Martin Südmeyer	4
4	Impaired neuron differentiation in GBA-associated Parkinson’s disease is linked to cell cycle defects in organoids 2023 ·npj Parkinson s Disease ·Isabel Rosety, Alise Žagare, Cláudia Saraiva, Sarah Nickels, Paul Antony, (unknown), Enrico Glaab, Rashi Halder, Sergiy Velychko, Thomas Rauen, Hans R. Schöler, Silvia Bolognin, Thomas Sauter, Javier Jarazo, Rejko Krüger, Jens C. Schwamborn	15
5	Machine learning for predicting neurodegenerative diseases in the general older population: a cohort study 2023 ·BMC Medical Research Methodology ·Gloria Aguayo, Lu Zhang, Michel Vaillant, Moses M. Ngari, Magali Perquin, Valérie Moran, Laëtitia Huiart, Rejko Krüger, Francisco Azuaje, Cyril Ferdynus, Guy Fagherazzi	11
6	Retrograde Procedural Memory in Parkinson's Disease 2022 ·Open Repository and Bibliography (University of Luxembourg) ·(unknown), Claire Pauly, Maxime Hansen, (unknown), Armin Rauschenberger, Anja Leist, Rejko Krüger	1
7	Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo 2022 ·Science Advances ·Fubo Cheng, (unknown), Chang Liu, Peter A. Barbuti, Libo Yu-Taeger, Nicolas Casadei, Jeannette Hübener‐Schmid, Jakob Admard, Karsten Boldt, Katrin Junger, Marius Ueffing, Henry Houlden, Manu Sharma, Rejko Krüger, (unknown), Thomas Ott, Olaf Rieß	6
8	PINK1 Protects against Staurosporine-Induced Apoptosis by Interacting with Beclin1 and Impairing Its Pro-Apoptotic Cleavage 2022 ·Cells ·F. Brunelli, Liliana Torosantucci, Vania Gelmetti, (unknown), Anne Grünewald, Rejko Krüger, Giuseppe Arena, Enza Maria Valente	16
9	Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting 2022 ·BMJ Open ·Francesca Bowring, Jessica Welch, (unknown), Christine Lo, Michael Lawton, Patricia Sulzer, Anne-Marie Hanff, Rejko Krüger, Inga Liepelt‐Scarfone, (unknown)	5
10	Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase 2021 ·npj Parkinson s Disease ·Anouke van Rumund, Lukas Pavelka, Rianne A.J. Esselink, (unknown), Ron A. Wevers, Brit Mollenhauer, Rejko Krüger, Bastiaan R. Bloem, Marcel M. Verbeek	16
11	Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire 2021 ·Neurological Sciences ·Sara Becker, Claire Pauly, Michael Lawton, Géraldine Hipp, Francesca Bowring, Patricia Sulzer, (unknown), Rejko Krüger, Thomas Gasser, Inga Liepelt‐Scarfone	3
12	Mitochondria interaction networks show altered topological patterns in Parkinson’s disease 2020 ·npj Systems Biology and Applications ·Massimiliano Zanin, (unknown), Paul Antony, (unknown), (unknown), (unknown), Peter A. Barbuti, Aidos Baumuratov, Dajana Großmann, Christophe Capelle, (unknown), Rudi Balling, Markus Ollert, Rejko Krüger, Nico J. Diederich, Feng He	8
13	Connecting environmental exposure and neurodegeneration using cheminformatics and high resolution mass spectrometry: potential and challenges 2019 ·Environmental Science Processes & Impacts ·Emma Schymanski, Nancy Baker, Antony Williams, Randolph R. Singh, Jean‐Pierre Trezzi, Paul Wilmes, Pierre Kolber, Rejko Krüger, Nicole Paczia, Carole L. Linster, Rudi Balling	16
14	Mutations in RHOT1 Disrupt Endoplasmic Reticulum–Mitochondria Contact Sites Interfering with Calcium Homeostasis and Mitochondrial Dynamics in Parkinson's Disease 2019 ·Antioxidants and Redox Signaling ·Dajana Großmann, (unknown), (unknown), David Scheibner, (unknown), François Massart, Doron Rapaport, Alexander Skupin, Aymeric Fouquier d’Hérouël, Manu Sharma, Jenny Ghelfi, Aleksandar Raković, Peter Lichtner, Paul Antony, Enrico Glaab, Patrick May, Kai Stefan Dimmer, Julia C. Fitzgerald, Anne Grünewald, Rejko Krüger	66
15	α-Synuclein in Parkinson’s disease: causal or bystander? 2019 ·Journal of Neural Transmission ·Peter Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Claßen, Christian Dresel, Wolfgang H. Jost, Rejko Krüger, Thomas Müller, Heinz Reichmann, Olaf Rieß, Alexander Storch, (unknown), Thilo van Eimeren, Hans‐Ullrich Völker, Jürgen Winkler, Konstanze F. Winklhofer, Ullrich Wüllner, Friederike Zunke, Camelia‐Maria Monoranu	83
16	The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p 2017 ·Scientific Reports ·Letizia Straniero, Valeria Rimoldi, Maura Samarani, Stefano Goldwurm, Alessio Di Fonzo, Rejko Krüger, Michela Deleidi, Massimo Aureli, Giulia Soldà, Stefano Duga, Rosanna Asselta	65
17	Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease breakdown → 2017 ·Science ·Lena F. Burbulla, Pingping Song, Joseph R. Mazzulli, Enrico Zampese, Yvette C. Wong, Sohee Jeon, David P. Santos, Judith Blanz, Carolin D. Obermaier, (unknown), Jeffrey N. Savas, Evangelos Kiskinis, Xiaoxi Zhuang, Rejko Krüger, D. James Surmeier, Dimitri Krainc	625
18	PB 20 Anodal tDCS over the left sensorimotor area improves motor function and suppresses cortical beta activity in Parkinson’s disease 2017 ·Clinical Neurophysiology ·(unknown), Barbara Wasserka, Marlieke Scholten, Rejko Krüger, Christian Plewnia, (unknown)	1
19	Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial 2013 ·Brain ·Daniel Weiß, Margarete Teresa Walach, Christoph Meisner, (unknown), Marlieke Scholten, Sorin Breit, Christian Plewnia, Benjamin Bender, Alireza Gharabaghi, Tobias Wächter, Rejko Krüger	155
20	Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease 2010 ·European Journal of Clinical Investigation ·Lena F. Burbulla, Guido Krebiehl, Rejko Krüger	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact